Amedeo Smart

Free Medical Literature Service

 

Amedeo

Cytomegalovirus Infection
  Free Subscription

Articles published in
Transplantation
    July 2026
  1. NASHAN B
    The Role of mTOR Inhibitors in CMV Prevention: An Overlooked Aspect of the Fourth International CMV Consensus Guidelines.
    Transplantation. 2026 Jul 21. doi: 10.1097/TP.0000000000005852.
    >> Share

    April 2026
  2. MANUEL O
    Implementation of Cytomegalovirus Cell-mediated Immune Monitoring in the Routine Clinical Practice for Low-risk Kidney Transplant Recipients: Are we There yet?
    Transplantation. 2026 Apr 21. doi: 10.1097/TP.0000000000005723.
    >> Share

  3. CASO JM, Fernandez-Ruiz M, Gonzalez E, Polanco N, et al
    Evaluation of an Immune-guided Prevention Strategy Against CMV Among Intermediate-risk Kidney Transplant Recipients: A Quasi-experimental Study.
    Transplantation. 2026 Apr 21. doi: 10.1097/TP.0000000000005694.
    >> Share

  4. MIEHRIG AH, Foresto RD, Tedesco-Silva H, Medina-Pestana J, et al
    DNAemia Thresholds to Discontinue Antivirals in Preemptive Management for Cytomegalovirus Seropositive Recipients After Kidney Transplantation.
    Transplantation. 2026 Apr 17. doi: 10.1097/TP.0000000000005695.
    >> Share

    September 2025
  5. GARDINER BJ, Lee SJ, Snell GI, Westall GP, et al
    Response to Letter: Global Immune Biomarkers and Donor Serostatus Can Predict Cytomegalovirus Infection Within Seropositive Lung Transplant Recipients.
    Transplantation. 2025 Sep 17. doi: 10.1097/TP.0000000000005531.
    >> Share

    August 2025
  6. DENG ZQ, Yan HJ, Tian D
    Predicting Cytomegalovirus Infection in Seropositive Lung Transplant Recipients: How to Improve the Predictive Performance?
    Transplantation. 2025 Aug 29. doi: 10.1097/TP.0000000000005517.
    >> Share

    May 2025
  7. GARDINER BJ, Lee SJ, Robertson AN, Snell GI, et al
    Global Immune Biomarkers and Donor Serostatus Can Predict Cytomegalovirus Infection Within Seropositive Lung Transplant Recipients.
    Transplantation. 2025 May 20. doi: 10.1097/TP.0000000000005422.
    >> Share

    April 2025
  8. KOTTON CN, Kumar D, Manuel O, Chou S, et al
    The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.
    Transplantation. 2025 Apr 9. doi: 10.1097/TP.0000000000005374.
    >> Share

  9. WONG G, Li J
    Standardizing Care and Management of Cytomegalovirus Infections in Solid Organ Transplant Recipients: Highlights From the Fourth Consensus Guidelines.
    Transplantation. 2025 Apr 9. doi: 10.1097/TP.0000000000005380.
    >> Share

    March 2025
  10. GARDINER BJ, Westall GP, Sester M, Torre-Cisneros J, et al
    Immune Monitoring Assays: Predicting Cytomegalovirus and Other Infections in Solid Organ Transplant Recipients.
    Transplantation. 2025;109:395-398.
    >> Share

    December 2024
  11. VERA-ARIAS CA, Garcia-Rios E, Perez-Romero P
    NPC-21: A Potential Game Changer in the Fight Against Cytomegalovirus Disease in Transplant Recipients.
    Transplantation. 2024 Dec 9. doi: 10.1097/TP.0000000000005284.
    >> Share

    November 2024
  12. ICHIMARU N, Natori Y, Alloway RR, Wojciechowski D, et al
    Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21).
    Transplantation. 2024 Nov 6. doi: 10.1097/TP.0000000000005260.
    >> Share

    October 2024
  13. BERTO CG, Kotton CN
    Promises and Pitfalls of CMV Cell-mediated Immunity in Solid Organ Transplant.
    Transplantation. 2024 Oct 15. doi: 10.1097/TP.0000000000005207.
    >> Share

    September 2024
  14. HORSTEN F, Chou S, Gillemot S, Debaveye Y, et al
    Dynamics and Evolution of Donor-derived Cytomegalovirus Infection in 3 Solid Organ Transplant Recipients With the Same Multiorgan Donor.
    Transplantation. 2024 Sep 30. doi: 10.1097/TP.0000000000005209.
    >> Share

    August 2024
  15. SOLERA JT, Ferreira VH, Cervera C, Hosseini-Moghaddam SM, et al
    Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study.
    Transplantation. 2024 Aug 20. doi: 10.1097/TP.0000000000005173.
    >> Share

    April 2024
  16. PENNINGTON KM, Martin MJ, Murad MH, Sanborn D, et al
    Risk Factors for Early Fungal Disease in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis.
    Transplantation. 2024;108:970-984.
    >> Share

    January 2024
  17. ROBERTS MB, Kotton CN
    Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
    Transplantation. 2024 Jan 26. doi: 10.1097/TP.0000000000004908.
    >> Share

  18. ROBERTS MB, Kotton CN
    Letermovir Prophylaxis After Kidney Transplantation: Another Tool but Not a Revolution Yet.
    Transplantation. 2024;108:7-9.
    >> Share

    December 2023
  19. QIU Y, Zhang Y, Teng M, Cheng S, et al
    Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Transplantation. 2023 Dec 5. doi: 10.1097/TP.0000000000004856.
    >> Share

    November 2023
  20. REUSING JO JR, Agena F, Kotton CN, Campana G, et al
    QuantiFERON-CMV as a Predictor of CMV Events During Preemptive Therapy in CMV-seropositive Kidney Transplant Recipients.
    Transplantation. 2023 Nov 22. doi: 10.1097/TP.0000000000004870.
    >> Share

    October 2023
  21. STEWART AG, Kotton CN
    What's New: Updates on Cytomegalovirus in Solid Organ Transplantation.
    Transplantation. 2023 Oct 30. doi: 10.1097/TP.0000000000004855.
    >> Share

    August 2023
  22. TONIATO DE REZENDE FRESCHI J, Cristelli MP, Viana LA, Ficher KN, et al
    A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial.
    Transplantation. 2023 Aug 1. doi: 10.1097/TP.0000000000004749.
    >> Share

    May 2023
  23. BLOM KB, Birkeland GK, Midtvedt K, Jenssen TG, et al
    Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management.
    Transplantation. 2023 May 26. doi: 10.1097/TP.0000000000004615.
    >> Share

  24. KOTTON CN
    The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes
    Transplantation. 2023 May 22. doi: 10.1097/TP.0000000000004616.
    >> Share

    April 2023
  25. VIANA LA, Cristelli MP, Basso G, Santos DW, et al
    Conversion to mTOR Inhibitor to Reduce the Incidence of Cytomegalovirus Recurrence in Kidney Transplant Recipients Receiving Preemptive Treatment: A Prospective, Randomized Trial.
    Transplantation. 2023 Apr 13. doi: 10.1097/TP.0000000000004559.
    >> Share

  26. PIERROTTI LC, Clemente WT
    New Perspectives in Cytomegalovirus After Transplant: The Role of Immunosuppressant Management.
    Transplantation. 2023 Apr 13. doi: 10.1097/TP.0000000000004560.
    >> Share

    March 2023
  27. HIGDON LE, Tan JC, Maltzman JS
    Infection, Rejection, and the Connection.
    Transplantation. 2023;107:584-595.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016